Top Story

NICE recommends Servier UK's first oncology treatment

Trifluridine/tipiracil is Servier UK’s first oncology product.

Read more

Bosutinib and pemetrexed recommended for routine use on the NHS....

Read more

Investigational therapy gets positive scientific opinion....

Read more

Aflibercept more clinically effective than existing first-line treatment....

Read more

Daratumumab is currently approved by the EC for monotherapy of adult patients with relapsed and refr...

Read more

Portfolio comprises the approved antibiotics Merrem, Zinforo and Zavicefta...

Read more

Deal boosts the pharma giant's oncology roster....

Read more

MINERVA study also showed reductions in healthcare costs....

Read more

Alzheimer’s Society supported researchers in conducting pilot study...

Read more

Dr. Amaya Virós and Dr. Thomas Wiesner announced as the 2016 winners....

Read more

Study involved 700 women living in Sweden between the ages of 70 and 92....

Read more